celecoxib has been researched along with Muscular Atrophy in 3 studies
Muscular Atrophy: Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.
Excerpt | Relevance | Reference |
---|---|---|
"Skeletal muscle atrophy with high prevalence can induce weakness and fatigability and place huge burden on both health and quality of life." | 1.62 | Silencing COX-2 blocks PDK1/TRAF4-induced AKT activation to inhibit fibrogenesis during skeletal muscle atrophy. ( Cao, J; Cao, X; Chang, J; Chen, H; Fang, L; Ge, D; Jiang, F; Qian, Z; Tang, J; Yang, L; Zhang, S, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kaneguchi, A | 1 |
Umehara, T | 1 |
Yamaoka, K | 1 |
Ozawa, J | 1 |
Zhang, L | 1 |
Li, M | 1 |
Wang, W | 1 |
Yu, W | 1 |
Liu, H | 1 |
Wang, K | 1 |
Chang, M | 1 |
Deng, C | 1 |
Ji, Y | 1 |
Shen, Y | 1 |
Qi, L | 1 |
Sun, H | 1 |
Chen, H | 1 |
Qian, Z | 1 |
Zhang, S | 1 |
Tang, J | 1 |
Fang, L | 1 |
Jiang, F | 1 |
Ge, D | 1 |
Chang, J | 1 |
Cao, J | 1 |
Yang, L | 1 |
Cao, X | 1 |
3 other studies available for celecoxib and Muscular Atrophy
Article | Year |
---|---|
Bilateral muscle atrophy after anterior cruciate ligament reconstruction in rats: Protective effects of anti-inflammatory drug celecoxib.
Topics: Animals; Anterior Cruciate Ligament Injuries; Anterior Cruciate Ligament Reconstruction; Anti-Inflam | 2022 |
Celecoxib alleviates denervation-induced muscle atrophy by suppressing inflammation and oxidative stress and improving microcirculation.
Topics: Celecoxib; Humans; Inflammation; Microcirculation; Muscle Denervation; Muscle, Skeletal; Muscular At | 2022 |
Silencing COX-2 blocks PDK1/TRAF4-induced AKT activation to inhibit fibrogenesis during skeletal muscle atrophy.
Topics: Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Gene Silencing; Humans; Mice; Mus | 2021 |